Wednesday, October 14, 2026

CBOE Holdings Inc Hosts Conference Call For Investors: (VIX) Over 4% Up In The Last 24 Hours

Via News Just in

July 24, 2023

CBOE Holdings Inc Hosts Conference Call For Investors: (VIX) Over 4% Up In The Last 24 Hours
(VIANEWS) - The company, CBOE Holdings Inc, is set to host investors and clients on a conference call on 8/4/2023 7:28:39 AM. The call comes after the company's earnings, which are set to be announced on 5/5/2023. Business Insider reported on the fact that investors, or members of the public who wish to dial in, can join the call by visiting https://event.choruscall.com/mediaframe/webcast.html?webcastid=2eWGOPtM, or by calling 1-877-255-4313 from the US, or 1-412-317-5466 internationally. CBOE (VIX) has been up by 4.78% for the last session's close. At 05:08 EST on Monday, 24 July, CBOE (VIX) is $14.25.

CBOE Range

About CBOE's daily highs and lows, it's 6.58% up from its trailing 24 hours low of $13.37 and 2.59% up from its trailing 24 hours high of $13.89. Concerning CBOE's yearly highs and lows, it's 0.21% up from its 52-week low and 59.34% down from its 52-week high.

Volatility

CBOE's last week, last month's, and last quarter's current intraday variation average was 0.23%, 0.11%, and 4.36%, respectively. CBOE's highest amplitude of average volatility was 2.34% (last week), 2.88% (last month), and 4.36% (last quarter), respectively.

Previous days news about CBOE (VIX)

  • CBOE holdings inc hosts conference call for investors. According to Business Insider on Saturday, 22 July, "The company, CBOE Holdings Inc, is set to host investors and clients on a conference call on 8/4/2023 7:28:39 AM. "

News about

  • According to FXStreet on Sunday, 23 July, "Friday, this effect wasn't powerful enough to return S&P 500 to the opening values as tech gyrated too much. "
  • According to DailyForex on Monday, 24 July, "It will also react to the ongoing earnings season, with 150 companies in the S&P 500 scheduled to publish their results. "
  • According to FXStreet on Sunday, 23 July, "However, it is worth noting that despite these corrections, the overall trend for the S&P 500 and the NASDAQ remains upward and robust, indicating healthy market conditions. "
  • According to DailyForex on Monday, 24 July, "It is crucial for investors to recognize that the S&P 500 index is not driven by all 500 constituent stocks; rather, approximately 8 major stocks heavily influence its movement.", "As a result, traders are keen on capitalizing on opportunities that arise each time the S&P 500 shows signs of exhaustion."
  • According to Business Insider on Saturday, 22 July, "The S&P 500 and the Dow Jones Industrial Average (DJIA) ended the week on a positive note, with gains of 0.69% and 2.08% respectively, marking the second consecutive week of gains. "
More news about CBOE (VIX).
Via News Just in

Breaking news and real-time updates on financial markets, business developments, and economic events from Via News.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Clinical Catalyst Season: Big-Pharma Data Flow, Regulatory Milestones, and a Thin AI-Drug Fringe
October 2026 conferences (EASD, IGCS, NACFC, HFSA) are producing a dense run of late-stage readouts from Novo Nordisk, Lilly, Roche, Bayer, Vertex and Galderma. Regulatory milestones are scheduled behind them: the ivonescimab BLA PDUFA date on 2026-11-14, FDA acceptance of Roche's vamikibart BLA, and Scholar Rock's EMA resubmission. The AI-and-finance angle is peripheral. It consists of the AI-designed drug Rentosertib and QAIAx, a speculative microcap whose trial claims (the QIII pilot, anticipated 2027-01-01, and a patent update) are forecasts and filings rather than data, so they warrant skepticism.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,372 source documents archived
Query this data → isubstrate.com